N-[1-[7-(1-benzofuran-2-ylmethyl)-5,6,8,9-tetrahydro-[1,2,4]triazolo[4,3-d][1,4]diazepin-3-yl]-3-methylbutyl]-5-(2-hydroxyethyl)furan-2-carboxamide

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 三唑并二氮卓类
• 英文名称: N-[1-[7-(1-benzofuran-2-ylmethyl)-5,6,8,9-tetrahydro-[1,2,4]triazolo[4,3-d][1,4]diazepin-3-yl]-3-methylbutyl]-5-(2-hydroxyethyl)furan-2-carboxamide
• 化学式: C₂₇H₃₃N₅O₄
• 分子量: 491.6
• InChiKey: NFWNGBDBRNDZJR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  36
• 可旋转键数：
  9
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.44
• 拓扑面积：
  110
• 氢给体数：
  2
• 氢受体数：
  7

文献信息

• identification of compounds that disperse tdp-43 inclusions
  申请人：WOLOZIN Benjamin

  公开号：US20140080780A1

  公开（公告）日：2014-03-20

  Herein, methods of modulating inclusion formation and stress granules in cells are described. The methods comprise contacting a cell with an inclusion inhibitor. Methods for screening for modulators of TDP-43 aggregation are also described.
• IDENTIFICATION OF COMPOUNDS THAT DISPERSE TDP-43 INCLUSIONS
  申请人：AQUINNAH PHARMACEUTICALS, INC.

  公开号：US20170088515A1

  公开（公告）日：2017-03-30

  Herein, compounds and compositions for use in treating diseases relating to inclusion formation and stress granules are described. Methods for screening for modulation of TDP-43 aggregation are also described.
• US9359363B2
  申请人：——

  公开号：US9359363B2

  公开（公告）日：2016-06-07